Legend
Please note that a short description of a certain column can be displayed when you move your mouse cursor over the column's header and hold it still. Below, a more detailed description is shown per column.
Effect: The variant's effect on the function of the gene/protein, displayed in the format 'R/C'. R is the value reported by the source (publication, submitter) and this classification may vary between records. C is the value concluded by the curator. Note that in some database the curator uses Summary records to give details on the classification of the variant.Values used: '+' indicating the variant affects function, '+?' probably affects function, '-' does not affect function, '-?' probably does not affect function, '?' effect unknown, '.' effect was not classified.
Exon: number of exon/intron containing variant; 2 = exon 2, 12i = intron 12, 2i_7i = from intron 2 to intron 7, 8i_9 = intron 8/exon 9 boundary, _1 = 5' to exon 1, 18_ = 3' of exon 18, _1_18_ = encompassing the entire 18-exon gene
DNA change (cDNA): description of variant at DNA level, based on a coding DNA reference sequence (following HGVS recommendations); e.g. c.123C>T, c.123_145del, c.123_126dup. For deletions/duplications extending beyond the reference transcript resp. {0}/{2} is used to replace del/dup. Extent of the deletion/duplication should be specified using the genomic description (g.). "-" indicates the variant described on genomic level does not affect the coding DNA reference sequence.
RNA change: description of variant at RNA level (following HGVS recommendations).
- r.123c>u
- r.? = unknown
- r.(?) = RNA not analysed but probably transcribed copy of DNA variant
- r.spl? = RNA not analysed but variant probably affects splicing
- r.(spl?) = RNA not analysed but variant may affect splicing
- r.0? = change expected to abolish transcription
Protein: description of variant at protein level (following HGVS recommendations).
- p.(Arg345Pro) = change predicted from DNA (RNA not analysed)
- p.Arg345Pro = change derived from RNA analysis
- p.? = unknown effect
- p.0? = probably no protein produced
Allele: On which allele is the variant located? Does not necessarily imply inheritance! 'Paternal' (confirmed or inferred), 'Maternal' (confirmed or inferred), 'Parent #1' or #2 for compound heterozygosity without having screened the parents, 'Unknown' for heterozygosity without having screened the parents, 'Both' for homozygozity.
Classification method: The method used for the clinical classification of this variant.
All options:
- ACMG
- ACGS
- EAHAD-CFDB
- ENIGMA
- IARC
- InSiGHT
- kConFab
- other
Clinical classification: Clinical classification of variant, preferably based on standardised criteria (e.g. ACMG), directed on the clinical consequences as published/submitted, indicated using an enriched system including inheritance: e.g. pathogenic, pathogenic (dominant), pathogenic (recessive), pathogenic (!), pathogenic (maternal), pathogenic (paternal). Standard inheritance is covered by dominant/recessive, imprinting by maternal/paternal. A '!' warns for exceptional circumstances to be explained in the 'Remarks' field (low penetrance, variants pathogenic in heterozygous state only, hypomorphic/hypermorphic variants, protective variants, etc.). Non-disease consequences (e.g. drug metabolism (pharmacogenetics), risk factor, blood group, tasting bitter) are indicated using additions to the benign classification; benign (dominant), benign (recessive), benign (!), etc. The value 'association' is used for variants associated with a phenotype and 'NA' for variants from in vitro/in silico records. NOTE: classification may differ from the opinion of the curator as given in a variant SUMMARY-record or the 'Functional effect concluded'). NOTE: pathogenic/likely pathogenic should go together with "variant (probably) affects function" In ClassFunctional.
All options:
- pathogenic
- pathogenic (dominant)
- pathogenic (recessive)
- pathogenic (!)
- pathogenic (maternal)
- pathogenic (paternal)
- likely pathogenic
- likely pathogenic (dominant)
- likely pathogenic (recessive)
- likely pathogenic (!)
- likely pathogenic (maternal)
- likely pathogenic (paternal)
- VUS
- VUS (!)
- likely benign
- likely benign (dominant)
- likely benign (recessive)
- likely benign (!)
- likely benign (maternal)
- likely benign (paternal)
- benign
- benign (dominant)
- benign (recessive)
- benign (!)
- benign (maternal)
- benign (paternal)
- conflicting
- association
- NA
DNA change (genomic) (hg19): HGVS description of variant at DNA level, based on the genomic (chromosomal) DNA reference sequence; e.g. g.12345678C>T, g.12345679del, g.12345678_12345890dup
DNA change (hg38): HGVS description of variant at DNA level, based on the hg38 genomic (chromosomal) eference sequence; e.g. g.12345678C>T, g.12345679del, g.12345678_12345890dup
Published as: listed only when different from "DNA change"; variant as reported originally (e.g. 521delT). Variants seen in animal models, tested in vitro, predicted from RNA analysis, etc. are described between brackets like c.(456C>G)
ISCN: description of the variant according to ISCN nomenclature
DB-ID: database ID of variant, grouping multiple observations of the same variant together, starting with the HGNC gene symbol, followed by an underscore (_) and a six digit number (e.g. DMD_012345). _000000 is used for variants where DNA was not analysed (change predicted from RNA analysis), variants seen in animal models or variants not seen in humans but functionally tested in vitro
Variant remarks: remarks regarding variant described, e.g. germline mosaicism in mother, 345 kb deletion, muscle RNA analysed, not in 200 control chromosomes tested, on founder haplotype, etc.
Reference: publication describing the variant submitted, incl. links to OMIM, PubMed or other source, e.g. "den Dunnen ASHG2003 P2346"
ClinVar ID: ID of variant in ClinVar database
dbSNP ID: the dbSNP ID
Origin: Origin of variant/record: Germline = in all cells, De novo = in all cells, but not in either parent, Germline/De novo (untested) = in all cells, parents not tested (use only when De novo is likely, e.g. isolated/sporadic cases with dominant disease), Somatic = present in a subset of cells, but not in either parent, Uniparental disomy = from parental disomy (maternal or paternal), CLASSIFICATION record = submitter only sharing variant classification (note another report may share Individual data), SUMMARY record = master summary record from curator (may link to another database), In vitro (cloned) = data resulting from in vitro functional assays, animal model = data from animal model, Artefact = false positive variant call, DUPLICATE record = variant already described on another chromosome (e.g. unbalanced translocation, duplicating transposition, 2nd fusion transcript, etc.)
All options:
- Germline
- De novo
- Germline/De novo (untested)
- Somatic
- Uniparental disomy
- Uniparental disomy, maternal allele
- Uniparental disomy, paternal allele
- CLASSIFICATION record
- SUMMARY record
- In vitro (cloned)
- In silico
- animal model
- Artefact
- DUPLICATE record
- Unknown
- Not applicable
Segregation: Indicates whether the variant segregates with the phenotype (yes), does not segregate with the phenotype (no) or segregation is unknown (?)
All options:
- ? = unknown
- yes = segregates with phenotype
- no = does not segregate with phenotype
- - = not applicable
Frequency: frequency in which the variant was found; e.g 5/760 chromosomes (in 5 of 760 chromosomes tested), 1/33 patients (in 1 of 33 patients analysed in study), 0.05 controls (in 5% of control cases tested)
Re-site: restriction enzyme recognition site created (+) or destroyed (-); e.g. BglII+;BamHI-
VIP: variant VIP-status was requested for matchmaking - need collaboration(s) to crack the case - please contact the submitter/curator.
NOTE: to get VIP status ask the curator.
Methylation: result of methylation test; GOM (gain of methylation), LOM (loss of methylation), 30% (30% methylated). NOTE: when several tests were done mention the method as well (e.g. MS-PCR 75%)

 Effect
|

 Exon
|

 DNA change (cDNA)
|

 RNA change
|

 Protein
|

 Classification method
|

 Clinical classification
|

 DNA change (genomic) (hg19)
|

 DNA change (hg38)
|

 Published as
|

 ISCN
|

 DB-ID
|
 Variant remarks
|

 Reference
|

 ClinVar ID
|

 dbSNP ID
|

 Origin
|

 Segregation
|

 Frequency
|

 Re-site
|

 VIP
|

 Methylation
|

 Owner
|
+?/. |
- |
c.3+3del |
r.0 |
p.0 |
- |
likely pathogenic (dominant) |
g.49582757del |
g.49188974del |
- |
- |
TUBA1A_000178 |
RNA analysis suggests alternative transcription initiation |
PubMed: Bournazos 2022 |
- |
- |
De novo |
- |
- |
- |
- |
- |
Johan den Dunnen |
-?/. |
- |
c.4-7C>T |
r.(=) |
p.(=) |
- |
likely benign |
g.49580623G>A |
g.49186840G>A |
TUBA1A(NM_001270399.1):c.4-7C>T |
- |
TUBA1A_000165 |
VKGL data sharing initiative Nederland |
- |
- |
- |
CLASSIFICATION record |
- |
- |
- |
- |
- |
VKGL-NL_Rotterdam |
+/+ |
2 |
c.4C>A |
r.(?) |
p.(Arg2Ser) |
ACMG |
pathogenic |
g.49580616G>T |
g.49186833G>T |
- |
- |
TUBA1A_000149 |
identified_by: Romaniello Eur Radiol, 2017 Pubmed_ID: 28677066 |
Journal: Hebebrand 2018, PubMed: Romaniello 2017 |
- |
- |
Germline |
yes |
- |
- |
- |
- |
Moritz Hebebrand |
+/. |
- |
c.5G>A |
r.(?) |
p.(Arg2His) |
- |
pathogenic |
g.49580615C>T |
g.49186832C>T |
TUBA1A(NM_006009.3):c.5G>A (p.R2H) |
- |
TUBA1A_000020 |
VKGL data sharing initiative Nederland |
- |
- |
- |
CLASSIFICATION record |
- |
- |
- |
- |
- |
VKGL-NL_Rotterdam |
+?/+? |
2 |
c.5G>A |
r.(?) |
p.(Arg2His) |
ACMG |
likely pathogenic |
g.49580615C>T |
g.49186832C>T |
- |
- |
TUBA1A_000020 |
- |
Journal: Hebebrand 2018 |
- |
- |
Germline |
yes |
- |
- |
- |
- |
Moritz Hebebrand |
+?/. |
- |
c.5G>A |
r.(?) |
p.(Arg2His) |
- |
likely pathogenic |
g.49580615C>T |
g.49186832C>T |
- |
- |
TUBA1A_000020 |
- |
PubMed: Srivastava 2014 |
- |
- |
De novo |
- |
- |
- |
- |
- |
Johan den Dunnen |
+/. |
- |
c.5G>A |
r.(?) |
p.(Arg2His) |
- |
pathogenic (dominant) |
g.49580615C>T |
g.49186832C>T |
- |
- |
TUBA1A_000020 |
- |
PubMed: Duerinckx 2020, PubMed: Duerinckx 2021 |
- |
- |
De novo |
- |
- |
- |
- |
- |
Johan den Dunnen |
+?/+? |
2 |
c.13A>C |
r.(?) |
p.(Ile5Leu) |
ACMG |
likely pathogenic |
g.49580607T>G |
g.49186824T>G |
- |
- |
TUBA1A_000148 |
identified_by: Jansen Neurology, 2011 Pubmed_ID: 21403111 |
Journal: Hebebrand 2018, PubMed: Jansen 2011 |
- |
- |
Germline |
yes |
- |
- |
- |
- |
Moritz Hebebrand |
+?/+? |
2 |
c.13A>C |
r.(?) |
p.(Ile5Leu) |
ACMG |
likely pathogenic |
g.49580607T>G |
g.49186824T>G |
- |
- |
TUBA1A_000148 |
identified_by: Jansen Neurology, 2011 Pubmed_ID: 21403111 |
Journal: Hebebrand 2018, PubMed: Jansen 2011 |
- |
- |
Germline |
yes |
- |
- |
- |
- |
Moritz Hebebrand |
+?/+? |
2 |
c.13A>C |
r.(?) |
p.(Ile5Leu) |
ACMG |
likely pathogenic |
g.49580607T>G |
g.49186824T>G |
- |
- |
TUBA1A_000148 |
identified_by: Jansen Neurology, 2011 Pubmed_ID: 21403111 |
Journal: Hebebrand 2018, PubMed: Jansen 2011 |
- |
- |
Germline |
yes |
- |
- |
- |
- |
Moritz Hebebrand |
+?/+? |
2 |
c.17C>G |
r.(?) |
p.(Ser6Cys) |
ACMG |
likely pathogenic |
g.49580603G>C |
g.49186820G>C |
- |
- |
TUBA1A_000147 |
- |
Journal: Hebebrand 2018 |
- |
- |
Germline |
yes |
- |
- |
- |
- |
Moritz Hebebrand |
+?/. |
- |
c.26T>C |
r.(?) |
p.(Val9Ala) |
- |
likely pathogenic |
g.49580594A>G |
- |
TUBA1A(NM_006009.3):c.26T>C (p.(Val9Ala)) |
- |
TUBA1A_000186 |
VKGL data sharing initiative Nederland |
- |
- |
- |
CLASSIFICATION record |
- |
- |
- |
- |
- |
VKGL-NL_Leiden |
+?/. |
- |
c.47T>C |
r.(?) |
p.(Ile16Thr) |
- |
likely pathogenic |
g.49580573A>G |
g.49186790A>G |
TUBA1A(NM_001270399.2):c.47T>C (p.I16T) |
- |
TUBA1A_000164 |
VKGL data sharing initiative Nederland |
- |
- |
- |
CLASSIFICATION record |
- |
- |
- |
- |
- |
VKGL-NL_Groningen |
+?/+? |
2 |
c.53A>G |
r.(?) |
p.(Asn18Ser) |
ACMG |
likely pathogenic |
g.49580567T>C |
g.49186784T>C |
- |
- |
TUBA1A_000144 |
- |
Journal: Hebebrand 2018 |
- |
- |
Germline |
yes |
- |
- |
- |
- |
Moritz Hebebrand |
+?/. |
- |
c.55G>A |
r.(?) |
p.(Ala19Thr) |
- |
likely pathogenic (dominant) |
g.49580565C>T |
g.49186782C>T |
- |
- |
TUBA1A_000187 |
- |
PubMed: Boissel 2017 |
- |
- |
De novo |
- |
- |
- |
- |
- |
Johan den Dunnen |
+/+ |
2 |
c.74G>T |
r.(?) |
p.(Cys25Phe) |
ACMG |
pathogenic |
g.49580546C>A |
g.49186763C>A |
- |
- |
TUBA1A_000143 |
identified_by: Yokoi Sci Rep, 2015 Pubmed_ID: 26493046 |
Journal: Hebebrand 2018, PubMed: Yokoi 2015 |
- |
- |
Germline |
yes |
- |
- |
- |
- |
Moritz Hebebrand |
-?/. |
- |
c.78G>A |
r.(?) |
p.(Leu26=) |
- |
likely benign |
g.49580542C>T |
g.49186759C>T |
- |
- |
TUBA1A_000158 |
VKGL data sharing initiative Nederland |
- |
- |
- |
CLASSIFICATION record |
- |
- |
- |
- |
- |
VKGL-NL_Nijmegen |
-?/. |
2 |
c.78G>A |
r.78G>A |
p.Leu26= |
- |
likely benign |
g.49580542C>T |
g.49186759C>T |
- |
- |
TUBA1A_000158 |
no effect on RNA |
- |
- |
- |
Germline/De novo (untested) |
- |
- |
- |
- |
- |
Tjakko van Ham |
+/+ |
2 |
c.79G>C |
r.(?) |
p.(Glu27Gln) |
ACMG |
pathogenic |
g.49580541C>G |
g.49186758C>G |
- |
- |
TUBA1A_000142 |
identified_by: Shimojima BMC Res Notes, 2014 Pubmed_ID: 25053001 |
Journal: Hebebrand 2018, PubMed: Shimojima 2014 |
- |
- |
Germline |
yes |
- |
- |
- |
- |
Moritz Hebebrand |
+?/+? |
2 |
c.82C>T |
r.(?) |
p.(His28Tyr) |
ACMG |
likely pathogenic |
g.49580538G>A |
g.49186755G>A |
- |
- |
TUBA1A_000141 |
- |
Journal: Hebebrand 2018 |
- |
- |
Germline |
yes |
- |
- |
- |
- |
Moritz Hebebrand |
-?/. |
- |
c.84C>T |
r.(?) |
p.(His28=) |
- |
likely benign |
g.49580536G>A |
g.49186753G>A |
TUBA1A(NM_001270399.1):c.84C>T (p.H28=) |
- |
TUBA1A_000019 |
VKGL data sharing initiative Nederland |
- |
- |
- |
CLASSIFICATION record |
- |
- |
- |
- |
- |
VKGL-NL_Rotterdam |
+?/. |
- |
c.90C>G |
r.(?) |
p.(Ile30Met) |
- |
likely pathogenic |
g.49580530G>C |
g.49186747G>C |
- |
- |
TUBA1A_000025 |
VKGL data sharing initiative Nederland |
- |
- |
- |
CLASSIFICATION record |
- |
- |
- |
- |
- |
VKGL-NL_Nijmegen |
+?/+? |
2 |
c.139G>C |
r.(?) |
p.(Asp47His) |
ACMG |
likely pathogenic |
g.49580481C>G |
g.49186698C>G |
- |
- |
TUBA1A_000140 |
- |
Journal: Hebebrand 2018 |
- |
- |
Germline |
yes |
- |
- |
- |
- |
Moritz Hebebrand |
+?/. |
- |
c.140A>G |
r.(?) |
p.(Asp47Gly) |
- |
likely pathogenic |
g.49580480T>C |
g.49186697T>C |
- |
- |
TUBA1A_000163 |
VKGL data sharing initiative Nederland |
- |
- |
- |
CLASSIFICATION record |
- |
- |
- |
- |
- |
VKGL-NL_Nijmegen |
+?/+? |
2 |
c.152C>T |
r.(?) |
p.(Thr51Ile) |
ACMG |
likely pathogenic |
g.49580468G>A |
g.49186685G>A |
- |
- |
TUBA1A_000139 |
- |
Journal: Hebebrand 2018 |
- |
- |
Germline |
yes |
- |
- |
- |
- |
Moritz Hebebrand |
+?/. |
2 |
c.161G>A |
r.(?) |
p.(Ser54Asn) |
- |
likely pathogenic |
g.49580459C>T |
g.49186676C>T |
- |
- |
TUBA1A_000001 |
- |
- |
- |
- |
Germline |
yes |
- |
- |
- |
- |
Enza Maria Valente |
+?/. |
2 |
c.161G>A |
r.(?) |
p.(Ser54Asn) |
- |
likely pathogenic |
g.49580459C>T |
g.49186676C>T |
- |
- |
TUBA1A_000001 |
- |
- |
- |
- |
Germline |
yes |
- |
- |
- |
- |
Enza Maria Valente |
+?/. |
2 |
c.161G>A |
r.(?) |
p.(Ser54Asn) |
- |
likely pathogenic |
g.49580459C>T |
g.49186676C>T |
- |
- |
TUBA1A_000001 |
- |
- |
- |
- |
Unknown |
yes |
- |
- |
- |
- |
Enza Maria Valente |
+/+ |
2 |
c.161G>A |
r.(?) |
p.(Ser54Asn) |
ACMG |
pathogenic |
g.49580459C>T |
g.49186676C>T |
- |
- |
TUBA1A_000001 |
identified_by: Romaniello Eur Radiol, 2017 Pubmed_ID: 28677066 |
Journal: Hebebrand 2018, PubMed: Romaniello 2017 |
- |
- |
Germline |
yes |
- |
- |
- |
- |
Moritz Hebebrand |
+/+ |
2 |
c.161G>A |
r.(?) |
p.(Ser54Asn) |
ACMG |
pathogenic |
g.49580459C>T |
g.49186676C>T |
- |
- |
TUBA1A_000001 |
identified_by: Romaniello Eur Radiol, 2017 Pubmed_ID: 28677066 |
Journal: Hebebrand 2018, PubMed: Romaniello 2017 |
- |
- |
Germline |
yes |
- |
- |
- |
- |
Moritz Hebebrand |
+/+ |
2 |
c.161G>A |
r.(?) |
p.(Ser54Asn) |
ACMG |
pathogenic |
g.49580459C>T |
g.49186676C>T |
- |
- |
TUBA1A_000001 |
identified_by: Romaniello Eur Radiol, 2017 Pubmed_ID: 28677066 |
Journal: Hebebrand 2018, PubMed: Romaniello 2017 |
- |
- |
Germline |
yes |
- |
- |
- |
- |
Moritz Hebebrand |
+?/+? |
2 |
c.162T>A |
r.(?) |
p.(Ser54Arg) |
ACMG |
likely pathogenic |
g.49580458A>T |
g.49186675A>T |
- |
- |
TUBA1A_000138 |
- |
Journal: Hebebrand 2018 |
- |
- |
Germline |
yes |
- |
- |
- |
- |
Moritz Hebebrand |
+/+ |
2 |
c.163G>A |
r.(?) |
p.(Glu55Lys) |
ACMG |
pathogenic |
g.49580457C>T |
g.49186674C>T |
- |
- |
TUBA1A_000137 |
identified_by: Morris-Rosendahl Clin Genet, 2008 Pubmed_ID: 18954413 |
Journal: Hebebrand 2018, PubMed: Morris-Rosendahl 2008 |
- |
- |
Germline |
yes |
- |
- |
- |
- |
Moritz Hebebrand |
+/+ |
2 |
c.167C>T |
r.(?) |
p.(Thr56Met) |
ACMG |
pathogenic |
g.49580453G>A |
g.49186670G>A |
- |
- |
TUBA1A_000136 |
identified_by: Bahi-Buisson Brain, 2014 Pubmed_ID: 24860126 |
Journal: Hebebrand 2018, PubMed: Bahi-Buisson 2014 |
- |
- |
Germline |
yes |
- |
- |
- |
- |
Moritz Hebebrand |
-/. |
- |
c.171G>T |
r.(?) |
p.(Gly57=) |
- |
benign |
g.49580449C>A |
g.49186666C>A |
TUBA1A(NM_006009.3):c.171G>T (p.G57=) |
- |
TUBA1A_000018 |
VKGL data sharing initiative Nederland |
- |
- |
- |
CLASSIFICATION record |
- |
- |
- |
- |
- |
VKGL-NL_Rotterdam |
+?/. |
- |
c.172G>A |
r.(?) |
p.(Ala58Thr) |
- |
likely pathogenic |
g.49580448C>T |
- |
- |
- |
TUBA1A_000169 |
VKGL data sharing initiative Nederland |
- |
- |
- |
CLASSIFICATION record |
- |
- |
- |
- |
- |
VKGL-NL_Nijmegen |
+?/. |
2 |
c.175G>A |
r.(?) |
p.(Gly59Ser) |
- |
likely pathogenic |
g.49580445C>T |
g.49186662C>T |
- |
- |
TUBA1A_000009 |
- |
- |
- |
- |
De novo |
yes |
- |
- |
- |
- |
Enza Maria Valente |
+/+ |
2 |
c.175G>A |
r.(?) |
p.(Gly59Ser) |
ACMG |
pathogenic |
g.49580445C>T |
g.49186662C>T |
- |
- |
TUBA1A_000009 |
identified_by: Romaniello Eur Radiol, 2017 Pubmed_ID: 28677066 |
Journal: Hebebrand 2018, PubMed: Romaniello 2017 |
- |
- |
Germline |
yes |
- |
- |
- |
- |
Moritz Hebebrand |
+?/. |
- |
c.184G>A |
r.(?) |
p.(Val62Met) |
- |
likely pathogenic |
g.49580436C>T |
- |
TUBA1A(NM_001270399.2):c.184G>A (p.V62M) |
- |
TUBA1A_000179 |
VKGL data sharing initiative Nederland |
- |
- |
- |
CLASSIFICATION record |
- |
- |
- |
- |
- |
VKGL-NL_VUmc |
-?/. |
- |
c.189C>T |
r.(?) |
p.(Pro63=) |
- |
likely benign |
g.49580431G>A |
g.49186648G>A |
TUBA1A(NM_006009.3):c.189C>T (p.P63=) |
- |
TUBA1A_000017 |
VKGL data sharing initiative Nederland |
- |
- |
- |
CLASSIFICATION record |
- |
- |
- |
- |
- |
VKGL-NL_Rotterdam |
+/+ |
2 |
c.190C>T |
r.(?) |
p.(Arg64Trp) |
ACMG |
pathogenic |
g.49580430G>A |
g.49186647G>A |
- |
- |
TUBA1A_000134 |
identified_by: Yokoi Sci Rep, 2015 Pubmed_ID: 26493046 |
Journal: Hebebrand 2018, PubMed: Yokoi 2015 |
- |
- |
Germline |
yes |
- |
- |
- |
- |
Moritz Hebebrand |
+?/. |
- |
c.197T>C |
r.(?) |
p.(Val66Ala) |
- |
likely pathogenic |
g.49580423A>G |
- |
- |
- |
TUBA1A_000180 |
VKGL data sharing initiative Nederland |
- |
- |
- |
CLASSIFICATION record |
- |
- |
- |
- |
- |
VKGL-NL_Nijmegen |
+?/. |
- |
c.203T>C |
r.(?) |
p.(Val68Ala) |
- |
likely pathogenic |
g.49580417A>G |
g.49186634A>G |
- |
- |
TUBA1A_000024 |
VKGL data sharing initiative Nederland |
- |
- |
- |
CLASSIFICATION record |
- |
- |
- |
- |
- |
VKGL-NL_Nijmegen |
+/+ |
2 |
c.209T>C |
r.(?) |
p.(Leu70Ser) |
ACMG |
pathogenic |
g.49580411A>G |
g.49186628A>G |
- |
- |
TUBA1A_000133 |
identified_by: Cushion Brain, 2013 Pubmed_ID: 23361065 |
Journal: Hebebrand 2018, PubMed: Cushion 2013 |
- |
- |
Germline |
yes |
- |
- |
- |
- |
Moritz Hebebrand |
+/+ |
2 |
c.214C>T |
r.(?) |
p.(Pro72Ser) |
ACMG |
pathogenic |
g.49580406G>A |
g.49186623G>A |
- |
- |
TUBA1A_000132 |
identified_by: Bahi-Buisson Brain, 2014 Pubmed_ID: 24860126 |
Journal: Hebebrand 2018, PubMed: Bahi-Buisson 2014 |
- |
- |
Germline |
yes |
- |
- |
- |
- |
Moritz Hebebrand |
+/+ |
2 |
c.215C>G |
r.(?) |
p.(Pro72Arg) |
ACMG |
pathogenic |
g.49580405G>C |
g.49186622G>C |
- |
- |
TUBA1A_000131 |
identified_by: Lelieveld Nat Neurosci, 2016 |
Journal: Hebebrand 2018, PubMed: Lelieveld 2016 |
- |
- |
Germline |
yes |
- |
- |
- |
- |
Moritz Hebebrand |
-/. |
- |
c.226+10C>T |
r.(=) |
p.(=) |
- |
benign |
g.49580384G>A |
g.49186601G>A |
TUBA1A(NM_001270399.1):c.226+10C>T |
- |
TUBA1A_000016 |
VKGL data sharing initiative Nederland |
- |
- |
- |
CLASSIFICATION record |
- |
- |
- |
- |
- |
VKGL-NL_Rotterdam |
?/. |
- |
c.227-1G>T |
r.spl? |
p.? |
- |
VUS |
g.49580242C>A |
- |
TUBA1A(NM_006009.4):c.227-1G>T |
- |
TUBA1A_000185 |
VKGL data sharing initiative Nederland |
- |
- |
- |
CLASSIFICATION record |
- |
- |
- |
- |
- |
VKGL-NL_VUmc |
-?/. |
- |
c.246C>T |
r.(?) |
p.(Thr82=) |
- |
likely benign |
g.49580222G>A |
g.49186439G>A |
TUBA1A(NM_001270399.1):c.246C>T (p.T82=) |
- |
TUBA1A_000015 |
VKGL data sharing initiative Nederland |
- |
- |
- |
CLASSIFICATION record |
- |
- |
- |
- |
- |
VKGL-NL_Rotterdam |
+?/+? |
3 |
c.269A>G |
r.(?) |
p.(Glu90Gly) |
ACMG |
likely pathogenic |
g.49580199T>C |
g.49186416T>C |
- |
- |
TUBA1A_000130 |
- |
Journal: Hebebrand 2018 |
- |
- |
Germline |
yes |
- |
- |
- |
- |
Moritz Hebebrand |
-?/. |
- |
c.273A>G |
r.(?) |
p.(Gln91=) |
- |
likely benign |
g.49580195T>C |
g.49186412T>C |
TUBA1A(NM_006009.3):c.273A>G (p.Q91=) |
- |
TUBA1A_000014 |
VKGL data sharing initiative Nederland |
- |
- |
- |
CLASSIFICATION record |
- |
- |
- |
- |
- |
VKGL-NL_Rotterdam |
+/+ |
3 |
c.274C>G |
r.(?) |
p.(Leu92Val) |
ACMG |
pathogenic |
g.49580194G>C |
g.49186411G>C |
- |
- |
TUBA1A_000129 |
identified_by: Kumar Hum Mol Genet, 2010 Pubmed_ID: 20466733 |
Journal: Hebebrand 2018, PubMed: Kumar 2010 |
- |
- |
Germline |
yes |
- |
- |
- |
- |
Moritz Hebebrand |
-?/. |
- |
c.276T>C |
r.(?) |
p.(Leu92=) |
- |
likely benign |
g.49580192A>G |
g.49186409A>G |
TUBA1A(NM_001270399.1):c.276T>C (p.L92=) |
- |
TUBA1A_000013 |
VKGL data sharing initiative Nederland |
- |
- |
- |
CLASSIFICATION record |
- |
- |
- |
- |
- |
VKGL-NL_Rotterdam |
+/+ |
3 |
c.283G>T |
r.(?) |
p.(Gly95Cys) |
ACMG |
pathogenic |
g.49580185C>A |
g.49186402C>A |
- |
- |
TUBA1A_000128 |
identified_by: Helbig Genet Med, 2016 |
Journal: Hebebrand 2018, PubMed: Helbig 2016 |
- |
- |
Germline |
yes |
- |
- |
- |
- |
Moritz Hebebrand |
+/. |
- |
c.283G>T |
r.(?) |
p.(Gly95Cys) |
ACMG |
pathogenic (dominant) |
g.49580185C>A |
g.49186402C>A |
- |
- |
TUBA1A_000128 |
- |
PubMed: Helbig 2016 |
- |
- |
De novo |
- |
- |
- |
- |
- |
Johan den Dunnen |
-/. |
- |
c.288A>G |
r.(?) |
p.(Lys96=) |
- |
benign |
g.49580180T>C |
g.49186397T>C |
TUBA1A(NM_006009.3):c.288A>G (p.K96=) |
- |
TUBA1A_000012 |
VKGL data sharing initiative Nederland |
- |
- |
- |
CLASSIFICATION record |
- |
- |
- |
- |
- |
VKGL-NL_Rotterdam |
-/. |
- |
c.288A>G |
r.(?) |
p.(Lys96=) |
- |
benign |
g.49580180T>C |
g.49186397T>C |
TUBA1A(NM_006009.3):c.288A>G (p.K96=) |
- |
TUBA1A_000012 |
VKGL data sharing initiative Nederland |
- |
- |
- |
CLASSIFICATION record |
- |
- |
- |
- |
- |
VKGL-NL_Nijmegen |
+/+ |
3 |
c.302A>G |
r.(?) |
p.(Asn101Ser) |
ACMG |
pathogenic |
g.49580166T>C |
g.49186383T>C |
- |
- |
TUBA1A_000127 |
identified_by: Bahi-Buisson Brain, 2014 Pubmed_ID: 24860126 |
Journal: Hebebrand 2018, PubMed: Bahi-Buisson 2014 |
- |
- |
Germline |
yes |
- |
- |
- |
- |
Moritz Hebebrand |
+?/. |
- |
c.302A>G |
r.(?) |
p.(Asn101Ser) |
ACMG |
likely pathogenic (dominant) |
g.49580166T>C |
- |
- |
- |
TUBA1A_000127 |
ACMG: PS2, PS4_SUP, PM2_SUP, PP2, PP3 |
PMID: 25059107 PMID: 30016746 |
VCV000625515.1 |
- |
De novo |
yes |
- |
- |
- |
- |
Andreas Laner |
+/+ |
2 |
c.320A>G |
r.(?) |
p.(His107Arg) |
ACMG |
pathogenic |
g.49580148T>C |
g.49186365T>C |
- |
- |
TUBA1A_000126 |
identified_by: Mencarelli J. Mol. Sci, 2017 Pubmed_ID: 29109381 |
Journal: Hebebrand 2018, PubMed: Mencarelli 2017 |
- |
- |
Germline |
yes |
- |
- |
- |
- |
Moritz Hebebrand |
?/. |
- |
c.329T>C |
r.(?) |
p.(Ile110Thr) |
ACMG |
likely pathogenic (dominant) |
g.49580139A>G |
g.49186356A>G |
- |
- |
TUBA1A_000181 |
ACMG: PM1, PS2_SUP, PM2_SUP, PP2, PP3; confirmed de novo |
- |
- |
- |
De novo |
- |
- |
- |
- |
- |
Andreas Laner |
+/+ |
3 |
c.337G>A |
r.(?) |
p.(Glu113Lys) |
ACMG |
pathogenic |
g.49580131C>T |
g.49186348C>T |
- |
- |
TUBA1A_000125 |
identified_by: Bahi-Buisson Brain, 2014 Pubmed_ID: 24860126 |
Journal: Hebebrand 2018, PubMed: Bahi-Buisson 2014 |
- |
- |
Germline |
yes |
- |
- |
- |
- |
Moritz Hebebrand |
?/. |
- |
c.344T>C |
r.(?) |
p.(Ile115Thr) |
- |
VUS |
g.49580124A>G |
g.49186341A>G |
TUBA1A(NM_006009.3):c.344T>C (p.I115T, p.(Ile115Thr)) |
- |
TUBA1A_000011 |
VKGL data sharing initiative Nederland |
- |
- |
- |
CLASSIFICATION record |
- |
- |
- |
- |
- |
VKGL-NL_Rotterdam |
+?/. |
- |
c.344T>C |
r.(?) |
p.(Ile115Thr) |
- |
likely pathogenic |
g.49580124A>G |
- |
TUBA1A(NM_006009.3):c.344T>C (p.I115T, p.(Ile115Thr)) |
- |
TUBA1A_000011 |
VKGL data sharing initiative Nederland |
- |
- |
- |
CLASSIFICATION record |
- |
- |
- |
- |
- |
VKGL-NL_Leiden |
+/+ |
3 |
c.352G>A |
r.(?) |
p.(Val118Met) |
ACMG |
pathogenic |
g.49580116C>T |
g.49186333C>T |
- |
- |
TUBA1A_000124 |
- |
Journal: Hebebrand 2018 |
- |
- |
Germline |
yes |
- |
- |
- |
- |
Moritz Hebebrand |
+/. |
- |
c.352G>A |
r.(?) |
p.(Val118Met) |
ACMG |
pathogenic (dominant) |
g.49580116C>T |
- |
- |
- |
TUBA1A_000124 |
ACMG: PS2_VSTR, PM5, PM2_SUP, PP2, PP3 |
PMID: 30744660, PMID: 25326637 |
VCV000217023.2 |
- |
Germline/De novo (untested) |
? |
- |
- |
- |
- |
Andreas Laner |
+?/. |
3 |
c.352G>C |
r.(?) |
p.(Val118Leu) |
- |
likely pathogenic |
g.49580116C>G |
g.49186333C>G |
- |
- |
TUBA1A_000008 |
- |
- |
- |
- |
De novo |
yes |
- |
- |
- |
- |
Enza Maria Valente |
+/+ |
3 |
c.352G>C |
r.(?) |
p.(Val118Leu) |
ACMG |
pathogenic |
g.49580116C>G |
g.49186333C>G |
- |
- |
TUBA1A_000008 |
identified_by: Romaniello Eur Radiol, 2017 Pubmed_ID: 28677066 |
Journal: Hebebrand 2018, PubMed: Romaniello 2017 |
- |
- |
Germline |
yes |
- |
- |
- |
- |
Moritz Hebebrand |
+/+ |
3 |
c.367C>T |
r.(?) |
p.(Arg123Cys) |
ACMG |
pathogenic |
g.49580101G>A |
g.49186318G>A |
- |
- |
TUBA1A_000123 |
identified_by: Bahi-Buisson Brain, 2014 Pubmed_ID: 24860126 |
Journal: Hebebrand 2018, PubMed: Bahi-Buisson 2014 |
- |
- |
Germline |
yes |
- |
- |
- |
- |
Moritz Hebebrand |
+?/. |
- |
c.367C>T |
r.(?) |
p.(Arg123Cys) |
- |
likely pathogenic |
g.49580101G>A |
g.49186318G>A |
TUBA1A(NM_001270399.1):c.367C>T (p.R123C) |
- |
TUBA1A_000123 |
VKGL data sharing initiative Nederland |
- |
- |
- |
CLASSIFICATION record |
- |
- |
- |
- |
- |
VKGL-NL_Rotterdam |
+?/. |
3 |
c.368G>A |
r.(?) |
p.(Arg123His) |
- |
likely pathogenic |
g.49580100C>T |
g.49186317C>T |
- |
- |
TUBA1A_000007 |
- |
- |
- |
- |
De novo |
yes |
- |
- |
- |
- |
Enza Maria Valente |
+/+ |
3 |
c.368G>A |
r.(?) |
p.(Arg123His) |
ACMG |
pathogenic |
g.49580100C>T |
g.49186317C>T |
- |
- |
TUBA1A_000007 |
identified_by: Romaniello Eur Radiol, 2017 Pubmed_ID: 28677066 |
Journal: Hebebrand 2018, PubMed: Romaniello 2017 |
- |
- |
Germline |
yes |
- |
- |
- |
- |
Moritz Hebebrand |
-?/. |
- |
c.378C>T |
r.(?) |
p.(Ala126=) |
- |
likely benign |
g.49579771G>A |
g.49185988G>A |
TUBA1A(NM_001270399.1):c.378C>T (p.(=)) |
- |
TUBA1A_000157 |
VKGL data sharing initiative Nederland |
- |
- |
- |
CLASSIFICATION record |
- |
- |
- |
- |
- |
VKGL-NL_Leiden |
?/. |
- |
c.379G>A |
r.(?) |
p.(Asp127Asn) |
- |
VUS |
g.49579770C>T |
g.49185987C>T |
TUBA1A(NM_006009.3):c.379G>A (p.(Asp127Asn)) |
- |
TUBA1A_000122 |
VKGL data sharing initiative Nederland |
- |
- |
- |
CLASSIFICATION record |
- |
- |
- |
- |
- |
VKGL-NL_Leiden |
+?/+? |
4 |
c.379G>A |
r.(?) |
p.(Asp127Asn) |
ACMG |
likely pathogenic |
g.49579770C>T |
g.49185987C>T |
- |
- |
TUBA1A_000122 |
- |
Journal: Hebebrand 2018 |
- |
- |
Germline |
yes |
- |
- |
- |
- |
Moritz Hebebrand |
+/+ |
4 |
c.381C>A |
r.(?) |
p.(Asp127Glu) |
ACMG |
pathogenic |
g.49579768G>T |
g.49185985G>T |
- |
- |
TUBA1A_000121 |
identified_by: Sato et al Brain Dev, 2018 Pubmed_ID: 29907476 |
Journal: Hebebrand 2018, PubMed: Sato 2018 |
- |
- |
Germline |
yes |
- |
- |
- |
- |
Moritz Hebebrand |
?/. |
- |
c.389C>T |
r.(?) |
p.(Thr130Met) |
- |
VUS |
g.49579760G>A |
- |
TUBA1A(NM_001270399.1):c.389C>T (p.T130M) |
- |
TUBA1A_000170 |
VKGL data sharing initiative Nederland |
- |
- |
- |
CLASSIFICATION record |
- |
- |
- |
- |
- |
VKGL-NL_Rotterdam |
-?/. |
- |
c.390G>C |
r.(?) |
p.(Thr130=) |
- |
likely benign |
g.49579759C>G |
g.49185976C>G |
TUBA1A(NM_001270399.1):c.390G>C (p.T130=) |
- |
TUBA1A_000042 |
VKGL data sharing initiative Nederland |
- |
- |
- |
CLASSIFICATION record |
- |
- |
- |
- |
- |
VKGL-NL_Rotterdam |
?/. |
- |
c.394C>G |
r.(?) |
p.(Leu132Val) |
- |
VUS |
g.49579755G>C |
g.49185972G>C |
- |
- |
TUBA1A_000023 |
VKGL data sharing initiative Nederland |
- |
- |
- |
CLASSIFICATION record |
- |
- |
- |
- |
- |
VKGL-NL_Nijmegen |
-?/. |
- |
c.396C>T |
r.(?) |
p.(Leu132=) |
- |
likely benign |
g.49579753G>A |
g.49185970G>A |
TUBA1A(NM_006009.3):c.396C>T (p.L132=) |
- |
TUBA1A_000041 |
VKGL data sharing initiative Nederland |
- |
- |
- |
CLASSIFICATION record |
- |
- |
- |
- |
- |
VKGL-NL_Rotterdam |
+?/. |
- |
c.401G>A |
r.(?) |
p.(Gly134Asp) |
- |
likely pathogenic |
g.49579748C>T |
- |
TUBA1A(NM_001270399.2):c.401G>A (p.G134D) |
- |
TUBA1A_000177 |
VKGL data sharing initiative Nederland |
- |
- |
- |
CLASSIFICATION record |
- |
- |
- |
- |
- |
VKGL-NL_VUmc |
+?/+? |
4 |
c.410T>A |
r.(?) |
p.(Val137Asp) |
ACMG |
likely pathogenic |
g.49579739A>T |
g.49185956A>T |
- |
- |
TUBA1A_000120 |
identified_by: Kumar Hum Mol Genet, 2010 Pubmed_ID: 20466733 |
Journal: Hebebrand 2018, PubMed: Kumar 2010 |
- |
- |
Germline |
yes |
- |
- |
- |
- |
Moritz Hebebrand |
+?/+? |
4 |
c.424G>A |
r.(?) |
(p.Gly142Ser) |
ACMG |
likely pathogenic |
g.49579725C>T |
g.49185942C>T |
- |
- |
TUBA1A_000118 |
- |
Journal: Hebebrand 2018 |
- |
- |
Germline |
yes |
- |
- |
- |
- |
Moritz Hebebrand |
+?/+? |
4 |
c.424G>T |
r.(?) |
p.(Gly142Cys) |
ACMG |
likely pathogenic |
g.49579725C>A |
g.49185942C>A |
- |
- |
TUBA1A_000117 |
- |
Journal: Hebebrand 2018 |
- |
- |
Germline |
yes |
- |
- |
- |
- |
Moritz Hebebrand |
+?/+? |
4 |
c.427G>A |
r.(?) |
p.(Gly143Arg) |
ACMG |
likely pathogenic |
g.49579722C>T |
g.49185939C>T |
- |
- |
TUBA1A_000116 |
- |
Journal: Hebebrand 2018 |
- |
- |
Germline |
yes |
- |
- |
- |
- |
Moritz Hebebrand |
+?/. |
4 |
c.449C>T |
r.(?) |
p.(Thr150Ile) |
- |
likely pathogenic |
g.49579700G>A |
g.49185917G>A |
- |
- |
TUBA1A_000006 |
- |
- |
- |
- |
De novo |
yes |
- |
- |
- |
- |
Enza Maria Valente |
+?/. |
4 |
c.449C>T |
r.(?) |
p.(Thr150Ile) |
- |
likely pathogenic |
g.49579700G>A |
g.49185917G>A |
- |
- |
TUBA1A_000006 |
- |
- |
- |
- |
De novo |
yes |
- |
- |
- |
- |
Enza Maria Valente |
+/+ |
4 |
c.449C>T |
r.(?) |
p.(Thr150Ile) |
ACMG |
pathogenic |
g.49579700G>A |
g.49185917G>A |
- |
- |
TUBA1A_000006 |
identified_by: Romaniello Eur Radiol, 2017 Pubmed_ID: 28677066 |
Journal: Hebebrand 2018, PubMed: Romaniello 2017 |
- |
- |
Germline |
yes |
- |
- |
- |
- |
Moritz Hebebrand |
+/+ |
4 |
c.449C>T |
r.(?) |
p.(Thr150Ile) |
ACMG |
pathogenic |
g.49579700G>A |
g.49185917G>A |
- |
- |
TUBA1A_000006 |
identified_by: Romaniello Eur Radiol, 2017 Pubmed_ID: 28677066 |
Journal: Hebebrand 2018, PubMed: Romaniello 2017 |
- |
- |
Germline |
yes |
- |
- |
- |
- |
Moritz Hebebrand |
+/. |
- |
c.452C>G |
r.(?) |
p.(Ser151Trp) |
- |
pathogenic |
g.49579697G>C |
g.49185914G>C |
TUBA1A(NM_006009.3):c.452C>G (p.S151W) |
- |
TUBA1A_000040 |
VKGL data sharing initiative Nederland |
- |
- |
- |
CLASSIFICATION record |
- |
- |
- |
- |
- |
VKGL-NL_Rotterdam |
-/. |
- |
c.453G>C |
r.(?) |
p.(Ser151=) |
- |
benign |
g.49579696C>G |
g.49185913C>G |
TUBA1A(NM_006009.3):c.453G>C (p.S151=) |
- |
TUBA1A_000022 |
VKGL data sharing initiative Nederland |
- |
- |
- |
CLASSIFICATION record |
- |
- |
- |
- |
- |
VKGL-NL_Rotterdam |
-/. |
- |
c.453G>C |
r.(?) |
p.(Ser151=) |
- |
benign |
g.49579696C>G |
g.49185913C>G |
TUBA1A(NM_006009.3):c.453G>C (p.S151=) |
- |
TUBA1A_000022 |
VKGL data sharing initiative Nederland |
- |
- |
- |
CLASSIFICATION record |
- |
- |
- |
- |
- |
VKGL-NL_Nijmegen |
+?/+? |
4 |
c.455T>A |
r.(?) |
p.(Leu152Gln) |
ACMG |
likely pathogenic |
g.49579694A>T |
g.49185911A>T |
- |
- |
TUBA1A_000114 |
- |
Journal: Hebebrand 2018 |
- |
- |
Germline |
yes |
- |
- |
- |
- |
Moritz Hebebrand |
+/. |
- |
c.465A>Y |
r.(?) |
p.(Glu155Asp) |
- |
pathogenic (dominant) |
g.49579684T>R |
g.49185901T>R |
Glu155Asp |
- |
TUBA1A_000176 |
- |
PubMed: Nissenkorn 2021 |
- |
- |
De novo |
- |
- |
- |
- |
- |
Johan den Dunnen |
?/. |
- |
c.467G>A |
r.(?) |
p.(Arg156His) |
ACMG |
likely pathogenic |
g.49579682C>T |
- |
- |
- |
TUBA1A_000171 |
Note on variant classification: Variants were classified using ACMG criteria (Richards et al., 2015) in November of 2020. These criteria are not applicable for novel gene identification and have limited utility for significant novel phenotype expansion. Classification is provided for established TUBA1A-associated tubulinopathy phenotypes, but excludes novel phenotype expansions (e.g. CFEOM) which are not yet well established in association with TUBA1A variants. |
- |
- |
- |
De novo |
yes |
- |
- |
- |
- |
Julie Jurgens |
+/+ |
4 |
c.473C>T |
r.(?) |
p.(Ser158Leu) |
ACMG |
pathogenic |
g.49579676G>A |
g.49185893G>A |
- |
- |
TUBA1A_000113 |
identified_by: Bahi-Buisson Brain, 2014 Pubmed_ID: 24860126 |
Journal: Hebebrand 2018, PubMed: Bahi-Buisson 2014 |
- |
- |
Germline |
yes |
- |
- |
- |
- |
Moritz Hebebrand |
+/+ |
4 |
c.481T>C |
r.(?) |
p.(Tyr161His) |
ACMG |
pathogenic |
g.49579668A>G |
g.49185885A>G |
- |
- |
TUBA1A_000111 |
identified_by: Poirier Eur J Hum Genetics, 2013 Pubmed_ID: 22948023 |
Journal: Hebebrand 2018, PubMed: Poirier 2013 |
- |
- |
Germline |
yes |
- |
- |
- |
- |
Moritz Hebebrand |
+?/+? |
4 |
c.481T>G |
r.(?) |
p.(Tyr161Asp) |
ACMG |
likely pathogenic |
g.49579668A>C |
g.49185885A>C |
- |
- |
TUBA1A_000112 |
- |
Journal: Hebebrand 2018 |
- |
- |
Germline |
yes |
- |
- |
- |
- |
Moritz Hebebrand |
+?/. |
- |
c.482A>G |
r.(?) |
p.(Tyr161Cys) |
- |
likely pathogenic |
g.49579667T>C |
- |
TUBA1A(NM_001270399.1):c.482A>G (p.(Tyr161Cys)) |
- |
TUBA1A_000184 |
VKGL data sharing initiative Nederland |
- |
- |
- |
CLASSIFICATION record |
- |
- |
- |
- |
- |
VKGL-NL_Leiden |
+/. |
- |
c.509C>G |
r.(?) |
p.(Ser170Cys) |
- |
pathogenic |
g.49579640G>C |
g.49185857G>C |
TUBA1A(NM_001270399.1):c.509C>G (p.S170C) |
- |
TUBA1A_000162 |
VKGL data sharing initiative Nederland |
- |
- |
- |
CLASSIFICATION record |
- |
- |
- |
- |
- |
VKGL-NL_Rotterdam |